Selected article for: "airway inflammation and asthmatic inflammation"

Author: Tynecka, Marlena; Moniuszko, Marcin; Eljaszewicz, Andrzej
Title: Old Friends with Unexploited Perspectives: Current Advances in Mesenchymal Stem Cell-Based Therapies in Asthma
  • Cord-id: k8vse47b
  • Document date: 2021_3_1
  • ID: k8vse47b
    Snippet: Mesenchymal stem cells (MSCs) have a great regenerative and immunomodulatory potential that was successfully tested in numerous pre-clinical and clinical studies of various degenerative, hematological and inflammatory disorders. Over the last few decades, substantial immunoregulatory effects of MSC treatment were widely observed in different experimental models of asthma. Therefore, it is tempting to speculate that stem cell-based treatment could become an attractive means to better suppress ast
    Document: Mesenchymal stem cells (MSCs) have a great regenerative and immunomodulatory potential that was successfully tested in numerous pre-clinical and clinical studies of various degenerative, hematological and inflammatory disorders. Over the last few decades, substantial immunoregulatory effects of MSC treatment were widely observed in different experimental models of asthma. Therefore, it is tempting to speculate that stem cell-based treatment could become an attractive means to better suppress asthmatic airway inflammation, especially in subjects resistant to currently available anti-inflammatory therapies. In this review, we discuss mechanisms accounting for potent immunosuppressive properties of MSCs and the rationale for their use in asthma. We describe in detail an intriguing interplay between MSCs and other crucial players in the immune system as well as lung microenvironment. Finally, we reveal the potential of MSCs in maintaining airway epithelial integrity and alleviating lung remodeling. [Image: see text]

    Search related documents:
    Co phrase search for related documents
    • accumulate body and acute distress respiratory: 1
    • accumulate body and acute distress respiratory syndrome: 1
    • activate cell and acute distress: 1
    • activate cell and acute distress respiratory: 1
    • activate cell and acute distress respiratory syndrome: 1
    • activate cell and adaptive immune response: 1, 2, 3
    • activating factor and acute distress: 1, 2, 3, 4, 5, 6
    • activating factor and acute distress respiratory: 1, 2, 3, 4, 5, 6
    • activating factor and acute distress respiratory syndrome: 1, 2, 3, 4, 5, 6
    • activation cell receptor and acute distress: 1
    • activation cell receptor and acute distress respiratory: 1
    • activation cell receptor and acute distress respiratory syndrome: 1
    • activation cell receptor and adaptive immune response: 1, 2
    • activation cell receptor and adaptive immune response innate: 1
    • actual role and acute distress: 1
    • actual role and acute distress respiratory: 1
    • actual role and acute distress respiratory syndrome: 1
    • acute distress and adaptive immune response: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22
    • acute distress and adaptive immune response innate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15